The effects of hormone therapy on renal hemodynamic function in transgender youth
This Study is
No Longer Enrolling
Description
One screening visit to see if you are eligible to participate, then one study visit prior to starting testosterone or estradiol and one study visit 3 months later.
Details
Age
Child to Adult
Eligibility
Transgender individuals planning on starting either testosterone or estradiol soon, age 17-30 years
Type of Study
Observational
Locations
Childrens Hospital Colorado
Outpatient CTRC
Study ID
Protocol Number: 20-0572
More information available at ClinicalTrials.gov: NCT04482920
Categories
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers